To investigate on the gender-specific actions of prednisone in IBD patients, we analyzed the expression of the mRNA of the anti-inflammatory GC-induced gene GILZ in intestinal biopsies obtained before starting GC treatment of a subgroup of female and male patients of the same cohort, as a predictive pharmacodynamic marker of GC efficacy. Here, TSC22D3 is linked to inflammatory bowel disease.